Clinical Trial Update: Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates for eltrombopag olamine in thrombocytopenia associated with chronic myeloid leukemia or myelofibrosis during tyrosine kinase inhibitor th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Accelerated Phase Chronic Myelogenous Leukemia Bcr-abl1-positive
• Blast Phase Chronic Myelogenous Leukemia Bcr-abl1-positive
• Myelofibrosis
• Phase Chronic Myelogenous Leukemia Bcr-abl1 Positive
• Thrombocytopenia

Drugs mentioned

• Eltrombopag Olamine (eltrombopag olamine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-02-01